Human cardiac progenitor spheroids exhibit enhanced engraftment potential

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Oltolina, Francesca ^a   Zamperone, Andrea ^a,f   Colangelo, Donato ^a   Gregoletto, Luca ^a   Reano, Simone ^a   Pietronave, Stefano ^a   Merlin, Simone ^a   Talmon, Maria ^a   Novelli, Eugenio ^b   Diena, Marco ^b   Nicoletti, Carmine ^c,d   Musarò, Antonio ^c,d   Filigheddu, Nicoletta ^a   Follenzi, Antonia ^a,e   Prat, Maria ^a,e  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b S Gaudenzio Hospital   (Italy)

^c Pasteur Institute   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Biotecnologie per la Ricerca Medica Applicata (BRMA)   (Italy)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; GELATINASE A; TELOMERASE; MESSENGER RNA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL AGGREGATION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENGRAFTMENT; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPHEROID CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEART; METABOLISM; MIDDLE AGED; MULTICELLULAR SPHEROID; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSPLANTATION; VERY ELDERLY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84945910862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137999     Document Type: Article

References (66)

1. Ratajczak MZ, Zuba-Surma E, Kucia M, Poniewierska A, Suszynska M, Ratajczak J. Pluripotent and multipotent stem cells in adult tissues. Adv Med Sci. 2012; 57: 1-17. doi: 10.2478/v10039-012-0020-z
2. Pavo N, Charwat S, Nyolczas N, Jakab A, Murlasits Z, Bergler-Klein J, et al. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol. Elsevier Ltd; 2014; 75: 12-24. doi: 10.1016/j.yjmcc.2014.06.016
3. Nabel EG. Cardiovascular insights from a premature aging syndrome: a translational story. Trans Am Clin Climatol Assoc. 2012; 123: 221-5; discussion 225-6. Available: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=3540623&tool = pmcentrez&rendertype = abstract
4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014; 129: e28-e292. doi: 10.1161/01.cir.0000441139.02102.80
5. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. Elsevier Ltd; 2011; 378: 1847-57. doi: 10.1016/S0140-6736(11)61590-0
6. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, et al. Intracoronary cardiospherederived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014; 63: 110-22. doi: 10.1016/j.jacc.2013.08.724
7. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-102. doi: 10.1126/science.1164680
8. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-76. Available: http://www.ncbi. nlm.nih.gov/pubmed/14505575
9. Valente M, Nascimento DS, Cumano A, Pinto-do-Ó P. Sca-1(+) Cardiac Progenitor Cells and Heart-Making: A Critical Synopsis. Stem Cells Dev. 2014; 00. doi: 10.1089/scd.2014.0197
10. Keith MCL, Bolli R. "String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res. 2015; 116: 1216-30. doi: 10. 1161/CIRCRESAHA.116.305557
11. Pietronave S, Zamperone A, Oltolina F, Colangelo D, Follenzi A, Novelli E, et al. Monophasic and biphasic electrical stimulation induces a precardiac differentiation in progenitor cells isolated from human heart. Stem Cells Dev. 2014; 23: 888-98. doi: 10.1089/scd.2013.0375
12. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-21. doi: 10.1161/01. RES.0000147315.71699.51
13. Malliaras K, Marbán E. Moving beyond surrogate endpoints in cell therapy trials for heart disease. Stem Cells Transl Med. 2014; 3: 2-6. doi: 10.5966/sctm.2013-0104
14. Terrovitis JV V., Smith RRR, Marbán E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res. 2010; 106: 479-494. doi: 10.1161/CIRCRESAHA.109.208991
15. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation. 2000; 102: III56-61. Available: http://www.ncbi.nlm.nih.gov/pubmed/11082363
16. Zimmermann W-H, Didié M, Döker S, Melnychenko I, Naito H, Rogge C, et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res. 2006; 71: 419-29. doi: 10. 1016/j.cardiores.2006.03.023
17. Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260: 920-6. Available: http://www.ncbi.nlm. nih.gov/pubmed/8493529 PMID: 8493529
18. Zakharova L, Mastroeni D, Mutlu N, Molina M, Goldman S, Diethrich E, et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res. 2010; 87: 40-9. doi: 10.1093/cvr/cvq027
19. Forte G, Pietronave S, Nardone G, Zamperone A, Magnani E, Pagliari S, et al. Human cardiac progenitor cell grafts as unrestricted source of supernumerary cardiac cells in healthy murine hearts. Stem Cells. 2011; 29: 2051-61. doi: 10.1002/stem.763
20. Masuda S, Shimizu T, Yamato M, Okano T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev. 2008; 60: 277-85. doi: 10.1016/j.addr.2007.08.031
21. Yeh Y-C, Lee W-Y, Yu C-L, Hwang S-M, Chung M-F, Hsu L-W, et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials. 2010; 31: 6444-53. doi: 10.1016/j.biomaterials.2010.04.069
22. Kutys ML, Doyle AD, Yamada KM. Regulation of cell adhesion and migration by cell-derived matrices. Exp Cell Res. 2013; 319: 2434-9. doi: 10.1016/j.yexcr.2013.05.030
23. Chimenti I, Smith RR, Li T-S, Gerstenblith G, Messina E, Giacomello A, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010; 106: 971-80. doi: 10.1161/CIRCRESAHA.109.210682
24. Lee W-Y, Chang Y-H, Yeh Y-C, Chen C-H, Lin KM, Huang C-C, et al. The use of injectable spherically symmetric cell aggregates self-Assembled in a thermo-responsive hydrogel for enhanced cell transplantation. Biomaterials. 2009; 30: 5505-13. doi: 10.1016/j.biomaterials.2009.07.006
25. Wang C-C, Chen C-H, Hwang S-M, Lin W-W, Huang C-H, Lee W-Y, et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells. 2009; 27: 724-32. doi: 10.1634/stemcells.2008-0944
26. Yang M-J, Chen C-H, Lin P-J, Huang C-H, Chen W, Sung H-W. Novel method of forming human embryoid bodies in a polystyrene dish surface-coated with a temperature-responsive methylcellulose hydrogel. Biomacromolecules. 2007; 8: 2746-52. doi: 10.1021/bm0704166
27. Lee W-Y, Wei H-J, Lin W-W, Yeh Y-C, Hwang S-M, Wang J-J, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials. 2011; 32: 5558-67. doi: 10.1016/j.biomaterials.2011.04.031
28. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37: e21. doi: 10.1093/nar/gkn1027
29. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest. 1991; 87: 986-95. doi: 10.1172/JCI115107 PMID: 1705569
30. Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J Cell Sci. 1998; 111 (Pt 2: 237-47. Available: http://www.ncbi.nlm.nih.gov/pubmed/9405310
31. Pietronave S, Forte G, Locarno D, Merlin S, Zamperone A, Nicotra G, et al. Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis. Am J Physiol Heart Circ Physiol. 2010; 298: H1155-65. doi: 10.1152/ajpheart.01323.2008
32. Santini MP, Tsao L, Monassier L, Theodoropoulos C, Carter J, Lara-Pezzi E, et al. Enhancing repair of the mammalian heart. Circ Res. 2007; 100: 1732-40. doi: 10.1161/CIRCRESAHA.107.148791
33. Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A. 2013; 110: 13839-44. doi: 10.1073/pnas. 1313192110
34. Sadat S, Gehmert S, Song Y-H, Yen Y, Bai X, Gaiser S, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007; 363: 674-9. doi: 10.1016/j.bbrc.2007.09.058
35. Son B-R, Marquez-Curtis L a, Kucia M, Wysoczynski M, Turner a R, Ratajczak J, et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006; 24: 1254-64. doi: 10.1634/stemcells.2005-0271
36. Taghavi S, George JC. Homing of stem cells to ischemic myocardium. Am J Transl Res. 2013; 5: 404-11. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3665914&tool = pmcentrez&rendertype = abstract
37. Wojakowski W, Tendera M, Michałowska A, Majka M, Kucia M, Mas̈lankiewicz K, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004; 110: 3213-20. doi: 10.1161/01.CIR.0000147609.39780.02
38. Miyamoto S, Katz BZ, Lafrenie RM, Yamada KM. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann N Y Acad Sci. 1998; 857: 119-29. Available: http://www.ncbi.nlm.nih.gov/pubmed/9917837
39. Huttenlocher A, Horwitz AR. Integrins in cell migration. Cold Spring Harb Perspect Biol. 2011; 3: a005074. doi: 10.1101/cshperspect.a005074
40. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 2008; 28: 223-32. doi: 10.1161/ATVBAHA.107. 158014
41. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol. 2003; 200: 448-64. doi: 10.1002/path.1400
42. Anversa P, Rota M, Urbanek K, Hosoda T, Sonnenblick EH, Leri A, et al. Myocardial aging-A stem cell problem. Basic Res Cardiol. 2005; 100: 482-93. doi: 10.1007/s00395-005-0554-3
43. Madonna R, De Caterina R, Willerson JT, Geng Y-J. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J. 2011; 32: 1190-6. doi: 10.1093/eurheartj/ehq450
44. Wu KH, Liu YL, Zhou B, Han ZC. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Eur J Cardiothorac Surg. 2006; 30: 770-81. doi: 10.1016/j.ejcts.2006.08.003
45. Li T-S, Cheng K, Lee S-T, Matsushita S, Davis D, Malliaras K, et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells. 2010; 28: 2088-98. doi: 10.1002/stem.532
46. Yamaguchi Y, Ohno J, Sato A, Kido H, Fukushima T. Mesenchymal stem cell spheroids exhibit enhanced in-vitro and in-vivo osteoregenerative potential. BMC Biotechnol. 2014; 14: 105. doi: 10. 1186/s12896-014-0105-9
47. Cao Z, Zhang G, Wang F, Liu H, Liu L, Han Y, et al. Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS One. 2013; 8: e82949. doi: 10.1371/journal.pone.0082949
48. Di Scipio F, Sprio AE, Folino A, Carere ME, Salamone P, Yang Z, et al. Injured cardiomyocytes promote dental pulp mesenchymal stem cell homing. Biochim Biophys Acta. 2014; 1840: 2152-61. doi: 10. 1016/j.bbagen.2014.03.005
49. Linke A, Müller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A. 2005; 102: 8966-71. doi: 10.1073/pnas.0502678102
50. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003; 4: 915-25. doi: 10.1038/nrm1261
51. Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T, et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008; 52: 1858-65. doi: 10.1016/j.jacc.2008. 06.052
52. Baxter RC. IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer. 2014; 14: 329-41. doi: 10.1038/nrc3720
53. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells. 2007; 25: 1761-8. doi: 10.1634/stemcells.2007-0022
54. Colangelo D, Osella D. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-Telomerase pharmacological approach? Curr Med Chem. 2005; 12: 3091-102. Available: http://www.ncbi.nlm.nih.gov/pubmed/16375703
55. Samsonraj RM, Raghunath M, Hui JH, Ling L, Nurcombe V, Cool SM. Telomere length analysis of human mesenchymal stem cells by quantitative PCR. Gene. Elsevier B.V.; 2013; 519: 348-55.
56. Giardini MA, Segatto M, da Silva MS, Nunes VS, Cano MIN. Telomere and telomerase biology. Prog Mol Biol Transl Sci. 2014; 125: 1-40. doi: 10.1016/B978-0-12-397898-1.00001-3
57. Ni A, Wu MJ, Chavala S. Sphere Formation Permits Oct4 Reprogramming of Ciliary Body Epithelial Cells into Induced Pluripotent Stem Cells. Stem Cells Dev. 2014; 23: 1-24. doi: 10.1089/scd.2014. 0064
58. Mosqueira D, Pagliari S, Uto K, Ebara M, Romanazzo S, Escobedo-Lucea C, et al. Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano. American Chemical Society; 2014; 8: 2033-47. doi: 10.1021/nn4058984
59. Daley WP, Yamada KM. ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr Opin Genet Dev. 2013; 23: 408-14. doi: 10.1016/j.gde.2013.05.005
60. Kim S-H, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol. 2011; 209: 139-51. doi: 10.1530/JOE-10-0377
61. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2006; 24: 23-33. doi: 10.1634/stemcells.2004-0176
62. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86: 588-610. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3081175&tool = pmcentrez&rendertype = abstract
63. Shirvaikar N, Marquez-Curtis LA, Janowska-Wieczorek A. Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP. Biochem Res Int. 2012; 2012: 685267. doi: 10.1155/2012/685267
64. Hindi SM, Shin J, Ogura Y, Li H, Kumar A. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS One. 2013; 8: e72121. doi: 10.1371/journal.pone.0072121
65. Mu X, Xiang G, Rathbone CR, Pan H, Bellayr IH, Walters TJ, et al. Slow-Adhering stem cells derived from injured skeletal muscle have improved regenerative capacity. Am J Pathol. 2011; 179: 931-41. doi: 10.1016/j.ajpath.2011.05.004
66. Cheng K, Shen D, Xie Y, Cingolani E, Malliaras K, Marbán E. Brief report: Mechanism of extravasation of infused stem cells. Stem Cells. 2012; 30: 2835-42. doi: 10.1002/stem.1184